HEALTH: The One-Time Shot That Could End Type 2 Diabetes. “Fractyl Health aims to address the limitations of current treatments by developing one-time gene therapy for type 2 diabetes. The company’s approach involves delivering an artificial gene to the pancreas, continuously producing the GLP-1 hormone. By doing so, there would be no need for weekly injections, and the therapeutic effects of the hormone could be sustained for years.”